CG
FOLD

Cutler Group’s Amicus Therapeutics FOLD Stock Holding History

Cutler Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,800
Closed -$16K – 5892
2021
Q1 		$16K Sell
1,800
-20,300
-92% -$314K ﹤0.01% 3382
2020
Q4 		$9K Buy
+22,100
New +$452K ﹤0.01% 3259
2020
Q1 		– Sell
-12,000
Closed -$2K – 4206
2019
Q4 		$2K Buy
+12,000
New +$110K ﹤0.01% 3434
2018
Q2 		– Sell
-23,400
Closed -$6K – 4412
2018
Q1 		$6K Sell
23,400
-65,700
-74% -$1,000K ﹤0.01% 3155
2017
Q4 		$39K Buy
89,100
+41,000
+85% +$563K ﹤0.01% 2049
2017
Q3 		$15K Buy
48,100
+40,900
+568% +$541K ﹤0.01% 3407
2017
Q2 		$6K Buy
7,200
+1,600
+29% +$12.9K ﹤0.01% 4657
2017
Q1 		$13K Sell
5,600
-29,300
-84% -$185K ﹤0.01% 3781
2016
Q4 		$111K Buy
34,900
+29,200
+512% +$202K ﹤0.01% 1819
2016
Q3 		$5K Buy
5,700
+2,700
+90% +$18.2K ﹤0.01% 4932
2016
Q2 		$8K Buy
3,000
+800
+36% +$5.59K ﹤0.01% 4410
2016
Q1 		$4K Sell
2,200
-1,600
-42% -$11.3K ﹤0.01% 5032
2015
Q4 		$6K Buy
+3,800
New +$34.2K ﹤0.01% 4696

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Cutler Group's FOLD Position: Q1 2023 in Review

Cutler Group sold out of Amicus Therapeutics (FOLD) in Q1 2023, closing a stake of 200 shares — an estimated $2K sold.

Cutler Group first reported a position in FOLD in Q4 2015 and held it in 12 quarters. The position peaked at $554K in Q3 2017. 226 funds tracked by Wall St. Rank hold FOLD as of Q1 2023.

  • Cutler Group reported no remaining Amicus Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 200 Amicus Therapeutics shares in Q1 2023, an estimated $2K.
  • Cutler Group first reported a position in Amicus Therapeutics in Q4 2015 and held it in 12 quarters.
  • Cutler Group's Amicus Therapeutics position peaked at $554K in Q3 2017.
  • 226 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.